A manufacturer specializing in ergonomic solutions designed for pain relief and enhanced posture.
2015
Pune (India)
Seed
Frido (operated by Arcatron Mobility Pvt. Ltd.) is a leading D2C brand revolutionizing ergonomic wellness through research-backed products for pain relief, posture correction, and mobility enhancement. The company emerged from a mission to address chronic discomfort experienced during the pandemic, leveraging Arcatron’s legacy in mobility solutions (including wheelchairs for Paralympic athletes). Frido has achieved a ₹200 crore annual recurring revenue (ARR) as of 2025, growing at 3x YoY.
Ultimate Pro Seat Cushion: Hi-Per foam design for lower back and tailbone support (40% of revenue).
Car Comfort Bundle: Neck rests, wedges and backrests for long drives.
Dual Gel Insoles: Arch support for plantar fasciitis (25% of revenue).
Deep Sleep Pillow: Cervical alignment for pain-free rest.
Orthopedic Shoes: 3D-printed, clinically validated designs for daily wear (launched 2025).
Frido Go Wheelchair: Self-propelled, foldable design for accessibility.
Raised $1.7 million in a 2023 seed round led by BL Taparia Family Office and Undisclosed amount in a 2024 Series A led by OrbiMed.
Partnered with Royal Challengers Bengaluru (RCB) as their official insole partner, enhancing sports performance visibility.
Launched India’s first ergonomic footwear line (2025), targeting plantar fasciitis and flat feet.
Online Sales (70%): Website: 70% of revenue (₹140 crore ARR).Marketplaces: Amazon, Flipkart, Swiggy Instamart (25%).
Offline Retail (5%): 1,000+ stores across Mumbai, Delhi, Bengaluru.
B2B (Corporate Wellness): Bulk orders for enterprises (e.g., IT parks, fleets).
B2C (85%): Urban millennials (60%), seniors (25%), athletes (15%).
B2B (15%): Corporates, hospitals, hospitality sectors.
RCB (Royal Challengers Bengaluru): Strategic sports partnership for performance insoles.
E-commerce Platforms: Amazon (“Amazon’s Choice” for insoles), Flipkart, Blinkit, Zepto.
Healthcare Institutions: Collaborations with 50+ hospitals for mobility aids.
Kaizzen: Strategic communications partner for brand narrative building.
Manufacturing Partners: Facilities in Gujarat and NCR for localized production.
Footwear Expansion: Target ₹500 crore revenue by 2026 through ortho-footwear, leveraging 3D scanning tech in offline stores.
Global Markets: Piloting in UAE and US via Amazon Global Selling.
Offline Experience Centers: Stores with podiatrists and gait analysis in Pune, Delhi, Bengaluru.
Regulatory Compliance: RBI guidelines on D2C credit and product certifications.
Counterfeit Products: Rising copycats in Tier 2/3 markets.
$1.7 Million
2
Undisclosed, Series A
as of February 19, 2024
-
as of N/A
-
as of N/A
B2V Ventures
and 2 more238
Mainstreet
N/A
Date | Round Name | Amount | Valuation | Revenue | Revenue Multiple | Investors |
---|---|---|---|---|---|---|
February 19, 2024 | Series A | Undisclosed | - | - | - | OrbiMed |
March 29, 2023 | Seed | $1.7 Million | - | - | - | B2V Ventures, MGA Ventures, Chona Family Office |